FMP
Vaxil Bio Ltd.
VXL.V
TSXV
Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company's lead product is ImMucin that has completed a Phase I/II clinical trial for the treatment of multiple myeloma. It is also developing a tuberculosis vaccine/treatment and a coronavirus (COVID-19) vaccine. The company has a collaboration agreement with The Tel Aviv Sourasky Medical Center for the company's research program to develop a potential peptide vaccine against COVID-19; and cooperative research and development agreement with U.S. Army Medical Research Institute of Infectious Diseases for testing CorVax for its ability to prevent COVID-19 in mice. The company was founded in 2006 and is headquartered in Toronto, Canada.
0.01 CAD
-0.005 (-50%)
About
ceo
Mr. David Goren
sector
Healthcare
industry
Biotechnology
website
https://www.vaxil-bio.com
exchange
TSXV
Description
Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company's lead product is ImMucin that has completed a Phase I/II clinical trial for the treatment of multiple myeloma. It is also developing a tuberculosis vaccine/treatment and a coronavirus (COVID-19) vaccine. The company has a collaboration agreement with The Tel Aviv Sourasky Medical Center for the company's research program to develop a potential peptide vaccine against COVID-19; and cooperative research and development agreement with U.S. Army Medical Research Institute of Infectious Diseases for testing CorVax for its abi...
CIK
N/A
ISIN
CA92243L1076
CUSIP
N/A
Address
3400 One First Canadian Place
Phone
N/A
Country
CA
Employee
N/A
IPO Date
Mar 30, 2010
Summary
CIK
-
Exchange
TSXV
Industry
Biotechnology
Sector
Healthcare
CUSIP
-
ISIN
CA92243L1076
Country
CA
Price
0.01
Beta
-3.58
Volume Avg.
57.39k
Market Cap
1.37M
Shares
-
52-Week
0.01-0.035
DCF
0.01
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1
P/B
-
Website
https://www.vaxil-bio.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest VXL.V News
It looks like there's no news available.
